MENU
+Compare
SRBT
Stock ticker: OTC
AS OF
Jan 12 closing price
Price
$0.14
Change
+$0.03 (+27.27%)
Capitalization
144.07M

SRBT stock forecast, quote, news & analysis

Shanrong Biotechnology Corp Is a holding company for select biotechnology, health, and wellness operations... Show more

SRBT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SRBT with price predictions
Jan 14, 2026

SRBT in upward trend: price rose above 50-day moving average on January 12, 2026

SRBT moved above its 50-day moving average on January 12, 2026 date and that indicates a change from a downward trend to an upward trend. In of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 43 cases where SRBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SRBT just turned positive on January 13, 2026. Looking at past instances where SRBT's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SRBT moved out of overbought territory on December 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SRBT as a result. In of 58 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SRBT broke above its upper Bollinger Band on December 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.476) is normal, around the industry mean (11.557). P/E Ratio (0.000) is within average values for comparable stocks, (118.890). SRBT has a moderately low Dividend Yield (0.009) as compared to the industry average of (0.028). P/S Ratio (0.233) is also within normal values, averaging (759.010).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Industry description

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

Market Cap

The average market capitalization across the Financial Conglomerates Industry is 181.84M. The market cap for tickers in the group ranges from 1 to 590.24B. IMAQU holds the highest valuation in this group at 590.24B. The lowest valued company is MDCE at 1.

High and low price notable news

The average weekly price growth across all stocks in the Financial Conglomerates Industry was 1%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was 60%. NGRC experienced the highest price growth at 90%, while MTLK experienced the biggest fall at -69%.

Volume

The average weekly volume growth across all stocks in the Financial Conglomerates Industry was 57%. For the same stocks of the Industry, the average monthly volume growth was 24% and the average quarterly volume growth was -6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 87
Price Growth Rating: 57
SMR Rating: 96
Profit Risk Rating: 99
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
SRBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry FinancialConglomerates

Profile
Fundamentals
Details
Industry
N/A
Address
370 Amapola Avenue
Phone
+1 424 358-1046
Employees
3
Web
http://www.srbtmerger.com